What is Bisu?
Bisu is a pioneering health IoT startup dedicated to the development of sophisticated at-home health tracking devices. At the core of its product suite is microfluidic lab-on-a-chip technology, which enables precise, laboratory-grade analysis in a consumer-friendly format. By bridging the gap between clinical diagnostics and personal wellness, Bisu empowers users to monitor physiological markers with high accuracy. The company has established a strong reputation within the industry, evidenced by its participation in the HAX hardware accelerator and recognition from prestigious organizations such as Johnson and Johnson Innovation and MedTech Innovator. Its market position is defined by a commitment to scientific rigor and user-centric design, aiming to transform how individuals interact with their own health data.
How much funding has Bisu raised?
Bisu has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2021): $3.2M with participation from 15th Rock Ventures, QUAD, Pacifico Investments, ASICS Ventures Corporation, and SOSV
Key Investors in Bisu
15th Rock Ventures
A venture capital firm specializing in the enhancement of human capabilities through technology, with a focus on robotics and AI-driven innovation.
SOSV
A multi-stage venture capital investor that provides both intellectual and financial capital to accelerate the growth of transformative startup ideas.
QUAD
An investment entity participating in the funding round to support the advancement of health-tech infrastructure.
What's next for Bisu?
With this recent capital, Bisu is well-positioned to accelerate its product development cycle and expand its market reach. The strategic focus will likely shift toward optimizing manufacturing processes for its microfluidic devices and securing necessary regulatory clearances for broader commercial deployment. Furthermore, the company is expected to leverage its existing network of industry partners to integrate its diagnostic solutions into broader digital health ecosystems. As Bisu continues to refine its technology, the focus will remain on scaling production while maintaining the high standards of accuracy that have earned it numerous accolades. The company's trajectory suggests a move toward becoming a foundational player in the future of personalized, data-driven healthcare.
See full Bisu company page